Kate Haviland's Net Worth

Kate Haviland's net worth is estimated to be at least $9,068,211.11 as of 07/23/2024. CoreStreet's estimation of Kate Haviland's net worth is based on their sale of stock and current holding of stock.

Kate Haviland is CEO at Blueprint Medicines Corp. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 12,464 units of BPMC stock on 03/07/2024. Their biggest sale was on 03/01/2019 when they sold 21,644 units of Blueprint Medicines Corp stock for $1,840,822.20. They typically trade 2 times per year.

Total value of insider buys:
  • $48,378.00
Total value of insider sells:
  • $9,019,833.11
Most recent insider trade:
  • March 7, 2024

Kate Haviland's Insider Trading History

Blueprint Medicines CorpTitleAmountPriceTypeTotal Value
March 7, 2024
CEO12,464$90.69Sell$1,130,360.16
March 6, 2023
CEO6,640$45.69Sell$303,381.60
Nov. 3, 2022
CEO1,100$43.98Buy$48,378.00
Dec. 13, 2021
COO1,000$98.30Sell$98,300.00
June 28, 2021
COO1,000$90.24Sell$90,240.00
Oct. 16, 2020
COO13,334$101.23Sell$1,349,800.82
Sept. 22, 2020
COO3,143$85.49Sell$268,695.07
Jan. 10, 2020
COO7,763$85.16Sell$661,097.08
Aug. 19, 2019
COO95$85.00Sell$8,075.00
July 16, 2019
COO1,571$95.47Sell$149,983.37
June 17, 2019
COO11,952$96.46Sell$1,152,889.92
March 1, 2019
COO21,644$85.05Sell$1,840,822.20
Feb. 12, 2018
Insider6,775$74.93Sell$507,650.75
Oct. 5, 2017
Insider5,449$66.44Sell$362,031.56
Sept. 18, 2017
Insider6,356$60.03Sell$381,550.68
July 5, 2017
Insider7,265$54.66Sell$397,104.90
June 28, 2017
Insider6,357$50.00Sell$317,850.00